MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • 2019 International Congress

    A Case of Pregabalin induced Parkinsonism

    BC. Ari, F. Mayda Domac, G. Ozgen Kenangil (Istanbul, Turkey)

    Objective: Present a case of parkinsonism after administration of pregabalin, a rare case Background: Drug induced parkinsonism is the second common movement disorders after Parkinson’s…
  • 2019 International Congress

    Protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease

    S. Rajput, S. Sinha (New Delhi, India)

    Objective: Objective of our study was to evaluate protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease. Background: Parkinson’s disease (PD),…
  • 2019 International Congress

    Drug-Induced Parkinsonism May Persist Beyond Two Years After Discontinuation of Dopamine Transmission Blocking Agents

    J. Randhawa, R. Mehanna (Houston, TX, USA)

    Objective: To demonstrate that patients with drug-induced parkinsonism (DIP) can remain symptomatic beyond 6 months, what majority of literature suggests, after withdrawal of causative agents.…
  • 2019 International Congress

    Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: To report a case with re-emerging neuroleptic malignant syndrome (NMS) without re-introduced neuroleptic drugs. Background: Neuroleptic Malignant Syndrome (NMS) is a potentially fatal idiosyncratic…
  • 2019 International Congress

    Smartphone-based gait assessment of psychiatric patients on neuroleptics

    S. Hassin-Baer, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, Y. Rubel, K. Tchelet, Z. Yekutieli, M. Linder, H. Yahalom, G. Yahalom (Ramat-Gan, Israel)

    Objective: To characterize gait performance recorded from psychiatric patients on neuroleptics (PPN) and to compare it to Parkinson’s disease (PD) patients and healthy controls (HC).…
  • 2019 International Congress

    Waiting and waiting on Dopamine transporter imaging in drug induced parkinsonism

    JY. Yun, CY. Lee, MY. Chun, B. Jeon (Seoul, Republic of Korea)

    Objective: We discontinued offending medications in DIP or unmasked parkinsonism patients and delayed taking DAT images for one month. Background: Drug induced parkinsonism (DIP) may…
  • 2018 International Congress

    Salivary Alpha-Synuclein a new tool for the diagnosis of Parkinson’s disease?

    C. Aerts, C. Hirtz, V. Gonzalez, L. Collombier, M. De Verdal, C. Geny, M. Charif, E. Moulis, P. Fabbro-Peray, D. Deville Periere, P. Lapeyrie, G. Castelnovo, S. Lehmann (Nimes, France)

    Objective: The aim of the PARKSYN study was to test the utility of salivary alpha-synuclein (a-syn) concentration in the differential diagnosis between Parkinson's disease (PD)…
  • 2018 International Congress

    Levosulpiride Induced Movement Disorder: 7 cases

    D. Radhakrishnan, V. Goyal (New Delhi, India)

    Objective: Through this article we want to highlight extrapyramidal side effects of levosulpiride and need of its awareness among treating physicians. Background: Levosulpiride is a…
  • 2018 International Congress

    A case of tardive dyskinesia and parkinsonism following use of phentermine for weight loss

    R. Barmore, C. Hess, N. McFarland, M. Okun (Gainesville, FL, USA)

    Objective: To describe a case of tardive dyskinesia and parkinsonism following use of phentermine and briefly review the literature on tardive syndromes following use of…
  • 2018 International Congress

    Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan

    W. Lin, CY. Wei, HJ. Chen (ChangHua, Taiwan)

    Objective: The calcium channel blockers, such as flunarizine and cinnarizine, and rarely selective serotonin reuptake inhibitors and lithium can produce parkinsonism and tardive syndromes. Background:…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley